Improved long-term graft function in kidney transplant recipients with donor antigen-specific hyporeactivity

Pediatric Transplantation

Volumn 11, Issue 2, 2007, Pages 139-144

  Ferraris, Jorge R ^a,b   Tambutti, Mónica ^a   Prigoshin, Norma ^a  

^a HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^b Hospital Italiano ^*  (Argentina)

Author keywords

Donor antigen specific hyporeactivity; Glucocorticoid withdrawal; Graft function; Mixed lymphocyte culture; Renal transplantation

Indexed keywords

CALCINEURIN INHIBITOR; CYCLOSPORIN A; DACLIZUMAB; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADOLESCENT; ADULT; ANTIGEN SPECIFICITY; ARTICLE; CELL STIMULATION; CHILD; CHRONIC ALLOGRAFT NEPHROPATHY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE CLEARANCE; DONOR; DRUG DOSE REDUCTION; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; KIDNEY TRANSPLANTATION; LIVING DONOR; MALE; MIXED LYMPHOCYTE CULTURE; PERIPHERAL BLOOD MONONUCLEAR CELL; RECIPIENT;

ADOLESCENT; ANTIBODIES, MONOCLONAL; CALCINEURIN; CHILD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; LYMPHOCYTE CULTURE TEST, MIXED; MALE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33846639253     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2006.00621.x     Document Type: Article

References (22)

1. FERRARIS JR, GHEZZI L, WAISMAN G, KRMAR RT. Potential cardiovascular risk factors in paediatric renal transplant recipients. Pediatr Nephrol 2006: 21: 119-125.
2. WRAMMER L, MJÖNSTEDT L, RYDBERG L, OLAUSSON M. Cell-mediated immune responses in renal transplant recipients treated with cyclosporine and prednisolone with or without azathioprine. Scand J Immunol 1993: 37: 656-660.
3. FLECHNER SM, KERMAN RH, VAN BUREN CT, EPPS L, KAHAN BD. The use of cyclosporine in living-related renal transplantation. Donor-specific hyporesponsiveness and steroids withdrawal. Transplantation 1984: 38: 685-691.
4. REINSMOEN NL, MATAS AJ. Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity. Transplantation 1993: 55: 1017-1023.
5. INGULLI E, SHARMA V, SINGH A, SUTHANTHIRAN M, TEJANI A. Steroid withdrawal, rejection and the mixed lymphocyte reaction in children after renal transplantation. Kidney Int 1993: 44 (Suppl. 43): S36-S39.
6. REINSMOEN NL, MC SHERRY C, CHAVERS B, HERTZ MI, MATAS AJ. Correlation of donor antigen-specific hyporeactivity with allogenic microchimerism in kidney and lung recipients. Pediatr Nephrol 1995: 9: S35-S39.
7. GHOBRIAL I, MORRIS AG, BOOTH LJ. Clinical significance of in vitro donor-specific hyporesponsiveness in renal allograft recipients as demonstrated by the MLR. Transpl Int 1994: 7: 420-427.
8. BÖHMIG GA, SÄEMANN MD, BERGMANN M, et al. Long-term evaluation of proliferative donor antigen-specific reactivity in cadaveric kidney transplant recipients. Transpl Int 2000: 13: 187-193.
9. FERRARIS JR, TAMBUTTI ML, REDAL M, et al. Immunosuppressive activity of deflazacort in pediatric renal transplantation. Transplantation 1996: 62: 417-420.
10. FERRARIS JR, TAMBUTTI ML, REDAL MA, BUSTOS D, RAMIREZ JA, PRIGOSHIN N. Conversion from azathioprina to mycophenolate mofetil in pediatric renal transplant recipients with chronic rejection. Transplantation 2000: 70: 297-301.
11. FERRARIS JR, DUCA P, PRIGOSHIN N, et al. Mycophenolate mofetil and reduced doses of cyclosporine in pediatric liver transplantation with chronic renal dysfunction: changes in the immune responses. Pediatr Transplantation 2004: 8: 454-459.
12. FERRARIS JR, TAMBUTTI ML, CARDONI RL, PRIGOSHIN N. Conversion from cyclosporine A to tacrolimus in pediatric kidney transplant recipients with chronic rejection: Changes in the immune responses. Transplantation 2004: 77: 532-537.
13. SAYEGH MH. Why do we reject a graft? Role of indirect allorecognition in graft rejection. Kidney Int 1999: 56: 1967-1979.
14. HORNICK PI, MASON PD, YACOUD MH, ROSE ML, BATCHELOR R, LECHLER RI. Assessment of the contribution that direct allorecognition makes to the progression of chronic cardiac transplant rejection in humans. Circulation 1998: 97: 1257-1263.
15. VELLA JP, SPADAFORA FM, MURPHY B, et al. Indirect allorecognition of mayor histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction. Transplantation 1997: 64: 795-800.
16. BAKER RJ, HERNANDEZ-FUENTES MP, BROOKES PA, CHAUDHRY AN, LECHLER RI. The role of the allograft in the induction of donor-specific T cell hyporesponsiveness. Transplantation 2001: 72: 480-485.
17. GAME DS, HERNANDES-FUENTES MP, BAKER RJ, CHAUDHRY AN, LECHLER RI. Reversibility with interleukin 2 suggests that T cell anergy contribute to donor-specific hyporesponsiveness in renal transplant patients. J Am Soc Nephrol 2002: 13: 2983-2989.
18. + suppressor T cells. J Exp Med 2001: 193: 41-46.
19. + cells: A naturally occurring population of regulatory T cells. Blood 2001: 98: 2736-2744.
20. + T cells in human kidney transplant recipients. J Am Soc Nephrol 2003: 14: 1643-1651.
21. FERRARIS JR, FAINSTEIN-DAY P, GUTMAN R, et al. Effects of therapy with a new glucocorticoid, deflazacort, on linear growth and growth hormone secretion after renal transplantation. J Pediatr 1992: 121: 809-813.
22. FERRARIS JR, GHEZZI L, VALLEJO G, PIANTANIDA TJ, ARAUJO JL, SOJO ET. Improved long-term allograft function in pediatric renal transplantation with mycophenolate mofetil. Pediatr Transplantation 2005: 9: 178-182.